2nd Quarter - Report

ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
—
Expenses
$1,000,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to international and corporate tax reform.

LobbyistCovered position, as disclosed
SUSIE AHN —
ELIZABETH BROOKS —
HELEN DWIGHT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Issues related to Medicare Parts B and D pricing reform. S. 1971, the Chronic Kidney Disease Improvement in Research and Treatment Act. Issues related to CMS rulemaking [CMS-4190-F3, CMS-2482-P2].

LobbyistCovered position, as disclosed
SUSIE AHN —
ELIZABETH BROOKS —
HELEN DWIGHT —
THADDEUS FLOOD —
AARON W HUNTER —
STEPHANIE WISWALL —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: S. 1971 (117th)

Pharmacy PHA

Issues related to the 340B drug discount program. Discussions related to an appropriations hold on funding for a 2014 FDA rule that would move package inserts (PI) from paper to digital form-e-labeling.

LobbyistCovered position, as disclosed
SUSIE AHN —
ELIZABETH BROOKS —
HELEN DWIGHT —
AARON W HUNTER —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Issues relating to Intellectual Property protections for Covid-19 treatments and vaccines. S. 1435, the Affordable Prescriptions for Patients Act. H.R. 2873, the Affordable Prescriptions for Patients Through Promoting Competition Act. H.R. 2884, the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act.

LobbyistCovered position, as disclosed
SUSIE AHN —
ELIZABETH BROOKS —
HELEN DWIGHT —
AARON W HUNTER —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2884 (117th), H.R. 2873 (117th), S. 1435 (117th)

Health Issues HCR

H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act. H.R. 19 / S. 2164, the Lower Costs, More Cures Act. H.R. 3749, To amend title XXVII of the Public Health Services Act to expand the availability of coverage for lunch cancer screenings without the imposition of cost sharing. Issues related to Cures 2.0 discussion draft. Issues related to drug pricing. COVID-19 vaccine and therapy development. Issues related to health equity.

LobbyistCovered position, as disclosed
SUSIE AHN —
ELIZABETH BROOKS —
HELEN DWIGHT —
THADDEUS FLOOD —
AARON W HUNTER —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 19 (117th), H.R. 3749 (117th), H.R. 3 (117th), S. 2164 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.